Mourad Gumusboga

Medicine · Health Sciences

12h-index717citations26works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(20), Mycobacterium research and diagnosis(12), Pneumonia and Respiratory Infections(6), Pneumocystis jirovecii pneumonia detection and treatment(6), Cancer therapeutics and mechanisms(4)

Publications26 total

Echinococcus multilocularis screening in foxes of the Brussels Capital Region
Ghent University Academic Bibliography (Ghent University)·2025
Prevalence of non-tuberculous mycobacteria among people with acid-fast positive presumptive tuberculosis in Mali
PLoS ONE·2024· 1 citedOpen Access
Successful Mycobacterium tuberculosis culture isolation from tongue swabs: Results from both experimentally infected and clinical swabs from pulmonary tuberculosis patients
Diagnostic Microbiology and Infectious Disease·2024· 1 cited
Prevalence of non-tuberculous mycobacteria among people presumed to have tuberculosis, positive for acid-fast bacilli in Mali
2024Open Access
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
JAC-Antimicrobial Resistance·2022· 8 citedOpen Access
Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis
European Respiratory Journal·2021· 4 citedOpen Access
<i>Mycobacterium tuberculosis</i>borderline<i>rpoB</i>mutations: emerging from the unknown
European Respiratory Journal·2021· 22 citedOpen Access
The simple direct slide method is comparable to indirect Lowenstein Jensen proportion culture for detecting rifampicin resistant tuberculosis
Journal of Medical Microbiology·2021· 6 citedOpen Access
Finding the right balance between efficacy and tolerability for TB treatment: the search continues
The International Journal of Tuberculosis and Lung Disease·2021· 1 cited
Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes
PLoS ONE·2020· 9 citedOpen Access
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance
PLoS ONE·2020· 18 citedOpen Access
First-line tuberculosis treatment with double-dose rifampicin is well tolerated
The International Journal of Tuberculosis and Lung Disease·2020· 20 cited
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements
Respiratory Medicine·2019· 38 cited
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
Scientific Reports·2019· 53 citedOpen Access
Twenty years of rifampicin resistance surveillance in Bangladesh: periodic vs. continuous monitoring
The International Journal of Tuberculosis and Lung Disease·2018· 4 cited
Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
Clinical Infectious Diseases·2018· 26 citedOpen Access
The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide
International Journal of Mycobacteriology·2016· 10 citedOpen Access
Specific<i>gyrA</i>gene mutations predict poor treatment outcome in MDR-TB
Journal of Antimicrobial Chemotherapy·2015· 95 citedOpen Access
Disputed &lt;I&gt;rpo&lt;/I&gt;B mutations can frequently cause important rifampicin resistance among new tuberculosis patients
The International Journal of Tuberculosis and Lung Disease·2015· 97 cited
An operational study comparing microscopes and staining variations for tuberculosis LED FM
The International Journal of Tuberculosis and Lung Disease·2014· 4 cited
page 1 of 2Next →

Frequent Co-authors

Armand Van Deun(22), Bouke C. de Jong(19), Tom Decroo(9), Leen Rigouts(8), K. J. M. Aung(6), M. Anwar Hossain(6), M A Hossain(5), Aung Kya Jai Maug(5), Nimer Ortuño‐Gutiérrez(4), Willem Bram de Rijk(3), Hans L. Rieder(3), Wim Mulders(3), Tine Demeulenaere(3), Lutgarde Lynen(3), Cécile Uwizeye(2), Pim de Rijk(2), K. Fissette(2), Gabriela Torrea(2), Willy Ssengooba(2), Moses Joloba(2)